An investigation of fungal contamination in a hospital setting.
Authors
Johnson M; Rao C; Kreiss K
Source
American Industrial Hygiene Conference and Exposition, June 2-7, 2001, New Orleans, Louisiana. Fairfax, VA: American Industrial Hygiene Association, 2001 Jun; :64
Link
NIOSHTIC No.
20041429
Abstract
An investigation was conducted at an 8-story hospital due to a reported cluster of work-related asthma on the eighth floor of the facility. There has been ongoing renovation throughout the building for the past 5 years. The occupants reported occasional severe water damage from roof leaks. Although, there were no obvious signs of mold contamination, fungi were suspected because of the occupant complaints and the historical water damage. A survey for fungal contamination was conducted on the two top floors of the facility. Spore trap sampling was performed inside the wall and in the ambient indoor air. Bulk samples of the ceiling were analyzed for fungal growth. The bulk sample analyses showed extensive fungal contamination (Cladosporium elatum and Geomyces pannorum) on the ceiling material. The in-wall spore concentrations ranged from 5.3 x 10(2) to 5.3 x 19(5) spores/m3 (primarily of the genera Aspergillus/Penicillium, Geomyces and Cladosporium). Ambient indoor air concentrations ranged from 1.1 x 10(2) to 3.6 X 10(3) spores/m3 in which the genera Cladosporium and Geomyces accounted for 30 to 60% of the total spore counts. We documented inter-floor pathways for migration of fungal spores between the wall cavities, the ceiling cavities and the occupied space. Spore concentration in the elevator was 3.6 x 10(3) spores/m3, the highest quiescent ambient air level found in the facility. The elevator may have been a significant fungal pathway between floors. Our findings support the need for aggressive source and pathway identification even in the absence of visible mold or water damage.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.